| Human germinal centres engage memory and naive B cells after influenza vaccination JS Turner, JQ Zhou, J Han, AJ Schmitz, AA Rizk, WB Alsoussi, T Lei, ... Nature 586 (7827), 127-132, 2020 | 211 | 2020 |
| Genome-wide CRISPR/Cas9 screen identifies host factors essential for influenza virus replication J Han, JT Perez, C Chen, Y Li, A Benitez, M Kandasamy, Y Lee, ... Cell reports 23 (2), 596-607, 2018 | 207 | 2018 |
| Broadly neutralizing antibodies target a haemagglutinin anchor epitope JJ Guthmiller, J Han, HA Utset, L Li, LYL Lan, C Henry, CT Stamper, ... Nature 602 (7896), 314-320, 2022 | 80 | 2022 |
| Influenza virus: small molecule therapeutics and mechanisms of antiviral resistance J Han, J Perez, A Schafer, H Cheng, N Peet, L Rong, B Manicassamy Current medicinal chemistry 25 (38), 5115-5127, 2018 | 72 | 2018 |
| Polyreactive broadly neutralizing B cells are selected to provide defense against pandemic threat influenza viruses JJ Guthmiller, LYL Lan, ML Fernández-Quintero, J Han, HA Utset, DJ Bitar, ... Immunity 53 (6), 1230-1244. e5, 2020 | 69 | 2020 |
| Interactions with actin monomers, actin filaments, and Arp2/3 complex define the roles of WASP family proteins and cortactin in coordinately regulating branched actin networks LA Helgeson, JG Prendergast, AR Wagner, M Rodnick-Smith, BJ Nolen Journal of Biological Chemistry 289 (42), 28856-28869, 2014 | 66 | 2014 |
| Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans AH Ellebedy, R Nachbagauer, KJL Jackson, YN Dai, J Han, WB Alsoussi, ... Proceedings of the National Academy of Sciences 117 (30), 17957-17964, 2020 | 62 | 2020 |
| First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes JJ Guthmiller, J Han, L Li, AW Freyn, STH Liu, O Stovicek, CT Stamper, ... Science translational medicine 13 (596), eabg4535, 2021 | 38 | 2021 |
| Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination J Han, AJ Schmitz, ST Richey, YN Dai, HL Turner, BM Mohammed, ... Cell reports 34 (4), 2021 | 33 | 2021 |
| A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike M Claireaux, TG Caniels, M de Gast, J Han, D Guerra, G Kerster, ... Nature communications 13 (1), 4539, 2022 | 32 | 2022 |
| The p150 isoform of ADAR1 blocks sustained RLR signaling and apoptosis during influenza virus infection OA Vogel, J Han, CY Liang, S Manicassamy, JT Perez, B Manicassamy PLoS pathogens 16 (9), e1008842, 2020 | 28 | 2020 |
| tenOever B J Han, JT Perez, C Chen, Y Li, A Benitez, M Kandasamy, Y Lee, ... Manicassamy B. Genome-wide CRISPR/Cas9 screen identifies host factors …, 2018 | 26 | 2018 |
| A cross-neutralizing antibody between HIV-1 and influenza virus CCD Lee, Y Watanabe, NC Wu, J Han, S Kumar, T Pholcharee, ... PLoS pathogens 17 (3), e1009407, 2021 | 23 | 2021 |
| Host factor Rab11a is critical for efficient assembly of influenza A virus genomic segments J Han, K Ganti, VK Sali, C Twigg, Y Zhang, S Manivasagam, CY Liang, ... PLoS pathogens 17 (5), e1009517, 2021 | 21 | 2021 |
| A vaccine displaying a trimeric influenza-A HA stem protein on capsid-like particles elicits potent and long-lasting protection in mice S Thrane, KL Aves, IEM Uddbäck, CM Janitzek, J Han, YR Yang, AB Ward, ... Vaccines 8 (3), 389, 2020 | 20 | 2020 |
| Rab11a mediates cell-cell spread and reassortment of influenza A virus genomes via tunneling nanotubes K Ganti, J Han, B Manicassamy, AC Lowen PLoS pathogens 17 (9), e1009321, 2021 | 17 | 2021 |
| B. tenOever, and B. Manicassamy. 2018. Genome-wide CRISPR/Cas9 screen identifies host factors essential for influenza virus replication J Han, JT Perez, C Chen, Y Li, A Benitez, M Kandasamy, Y Lee, ... Cell Rep 23, 596-607, 0 | 13 | |
| Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface X Zhu, J Han, W Sun, E Puente-Massaguer, W Yu, P Palese, F Krammer, ... Proceedings of the National Academy of Sciences 119 (21), e2200821119, 2022 | 12 | 2022 |
| Development of potential small molecule therapeutics for treatment of Ebola virus disease A Schafer, H Cheng, C Lee, R Du, J Han, J Perez, N Peet, ... Current medicinal chemistry 25 (38), 5177-5190, 2018 | 12 | 2018 |
| The pre-existing human antibody repertoire to computationally optimized influenza H1 hemagglutinin vaccines K Nagashima, JV Dzimianski, J Han, N Abbadi, AD Gingerich, F Royer, ... The Journal of Immunology 209 (1), 5-15, 2022 | 8 | 2022 |
